Deane F. Johnson Center Receives Ronald and Nancy Reagan Award

LOS ANGELES, May 28 Dr. Jeffrey Cummings, Medical Directorof The Deane F. Johnson Center for Neurotherapeutics at UCLA, received theprestigious Ronald and Nancy Reagan Research Award for the exceptional work heand his team devote themselves to, discovering new treatments and methods ofcare for patients with Alzheimers and other neurological disorders.

In his speech of acceptance at the annual National Alzheimer's Gala inWashington, Dr. Cummings applauded the tireless work of the center'sco-founder Kate Edelman Johnson, who established the foundation in 1999 inmemory of her late husband, former Time-Warner President Deane F. Johnson, whodied from this dreadful disease.

SOURCE Deane F. Johnson Center

Latest Press Release on General News

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterin...

Nicklaus Children's Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic c...

Cinesteam® Is a Deodorizing Support Tool for Palliative Care

Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FOR...

Philips Delivers First-quarter Results in Line With 2024 Performance Improvement Plan; Resolves the Respironics Personal Injury and Medical Monitoring Litigation in the Us for USD 1.1 Billion

April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 b...

eNeura Achieves Record-Breaking Sales and Announces Notice of Allowance for a New Patent on Prophylactic Treatment of Migraine Headache

Record sales in April accelerating the pathway to profitability New IP will lead the way in changing the way migraine headaches are addressed WEST PALM BEACH, Fla. , April 26, ...